8-K: TRxADE Health Announces Special $8.00 Cash Dividend and Strategic Asset Sales

TRxADE Health, Inc. declared a special cash dividend of $8.00 per share, funded by proceeds from the sale of its web-based market platform assets, and also divested its subsidiary Superlatus Inc.

Summary

• TRxADE Health, Inc. announced a special cash dividend of $8.00 per share of common stock.
• The dividend is payable to shareholders of record as of March 18, 2024, and will be paid on or about March 22, 2024.
• The dividend is funded by a portion of the proceeds from the sale of the company's web-based market platform assets.
• Trxade, Inc., a wholly-owned subsidiary, entered into a Subscription Agreement with Lafayette Energy Corp., investing up to $5.0 million in exchange for convertible preferred stock.
• The investment in Lafayette Energy Corp. will be made in two tranches of $2.5 million each, with the second tranche contingent on Lafayette successfully drilling and producing at least 100 barrels of oil.
• The company also sold all of the issued and outstanding stock of its subsidiary, Superlatus Inc., to Superlatus Foods Inc. for $1.00.
• As a result of the sale, Superlatus Inc. is no longer a subsidiary of TRxADE Health, Inc.

Sentiment

Score: 6

Explanation: The special dividend is a positive for shareholders, but the sale of Superlatus for $1 and the risky investment in oil and gas temper the overall sentiment. The company is clearly undergoing a significant strategic shift.

Positives

• The special cash dividend of $8.00 per share provides a significant return of capital to shareholders.
• The sale of the web-based market platform assets and Superlatus Inc. simplifies the company's structure.
• The investment in Lafayette Energy Corp. could provide a new avenue for growth and diversification.

Negatives

• The sale of Superlatus Inc. for $1.00 indicates a significant loss on that investment.
• The investment in Lafayette Energy Corp. is contingent on successful oil production, which carries inherent risks.

Risks

• The investment in Lafayette Energy Corp. is subject to the risks associated with oil and gas exploration and production.
• The company's ability to generate future revenue and profits is dependent on the success of its remaining business operations.
• The company faces risks related to agreements with third parties, ability to raise funding, and potential legal proceedings as detailed in their filings.

Future Outlook

The company's future performance is subject to risks and uncertainties, including the success of the investment in Lafayette Energy Corp. and the ability to raise future funding. The company has stated they undertake no obligation to update or revise any forward-looking statements.

Management Comments

• The special dividend is being paid using a portion of the proceeds from the closing of the recently announced sale of the Company's web-based market platform assets.

Industry Context

The strategic moves by TRxADE Health, including the sale of assets and investment in a new sector, reflect a potential shift in the company's focus and strategy. This is not uncommon for companies seeking to optimize their portfolio and explore new growth opportunities.

Comparison to Industry Standards

• The sale of a subsidiary for $1.00 is unusual and suggests a significant write-down of the asset's value, which is not typical in standard business transactions.
• The investment in a private oil and gas company is a departure from TRxADE Health's core business, which is not a common strategy for companies in the healthcare technology sector.
• The special dividend is a significant return of capital to shareholders, which is a positive move but is not a standard practice for companies in the growth phase.

Stakeholder Impact

• Shareholders will receive a special cash dividend of $8.00 per share.
• Employees of Superlatus Inc. are now employees of Superlatus Foods Inc.
• The company's strategic shift may impact future business relationships with customers and suppliers.

Next Steps

• The company will pay the special cash dividend on or about March 22, 2024.
• Trxade, Inc. will proceed with the investment in Lafayette Energy Corp., contingent on the successful drilling of an oil well.
• The company will continue to operate its remaining business segments.

Key Dates

Keywords

dividend, cash dividend, asset sale, investment, convertible preferred stock, oil and gas, subsidiary sale, Trxade Health, Lafayette Energy Corp, Superlatus Foods Inc